Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 5th edition, 486 pages Free download

Colorectal Neoplasms

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 301 articles: HTML format

Single Articles

November 2020
1. AHMED A, Halama N
   Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response.
   Anticancer Res. 2020;40:6367-6373.
   PubMed     Abstract available
   
   
   
2. NGAMKHAM J, Thuwajit C, Thuwajit P, Khamwachirapithak P, et al
   Overexpression of Pyruvate Carboxylase Is Correlated With Colorectal Cancer Progression and Supports Growth of Invasive Colon Cancer HT-29 Cell Line.
   Anticancer Res. 2020;40:6285-6293.
   PubMed     Abstract available
   
   
   
3. LIN PM, Lee HM, Huang CI, Tai TS, et al
   Synergistic Antiproliferative Effect of Ribociclib (LEE011) and 5-Fluorouracil on Human Colorectal Cancer.
   Anticancer Res. 2020;40:6265-6271.
   PubMed     Abstract available
   
   
   
4. MUSA M, Ouaret D, Bodmer WF
   In Vitro Analyses of Interactions Between Colonic Myofibroblasts and Colorectal Cancer Cells for Anticancer Study.
   Anticancer Res. 2020;40:6063-6073.
   PubMed     Abstract available
   
   
   
5. NAGATA M, Matsuda T, Hasegawa H, Utsumi M, et al
   Usefulness of Omentoplasty to Reduce Perineal Wound Complications in Abdominoperineal Resection After Neoadjuvant Chemoradiotherapy.
   Anticancer Res. 2020;40:6539-6543.
   PubMed     Abstract available
   
   
   
6. RYU S, Okamoto A, Nakashima K, Hara K, et al
   Usefulness of Preoperative Endoscopic Fluorescent Clip Marking in Laparoscopic Gastrointestinal Surgery.
   Anticancer Res. 2020;40:6517-6523.
   PubMed     Abstract available
   
   
   
7. HUANG WL, Luo CW, Chou CL, Yang CC, et al
   High Expression of UBE2B as a Poor Prognosis Factor in Patients With Rectal Cancer Following Chemoradiotherapy.
   Anticancer Res. 2020;40:6305-6317.
   PubMed     Abstract available
   
   
   October 2020
8. GO G, Yun CW, Yoon YM, Lim JH, et al
   Role of PrP(C) in Cancer Stem Cell Characteristics and Drug Resistance in Colon Cancer Cells.
   Anticancer Res. 2020;40:5611-5620.
   PubMed     Abstract available
   
   
   
9. YAMADA Y, Yoshimatsu K, Yokomizo H, Okayama S, et al
   Expression of ATP-binding Cassette Transporter 11 (ABCC11) Protein in Colon Cancer.
   Anticancer Res. 2020;40:5405-5409.
   PubMed     Abstract available
   
   
   
10. JONSSON G, Philipson L, Villman K, Valachis A, et al
    Upfront Radiotherapy in Patients With Asymptomatic Incurable Rectal Cancer: A Retrospective Cohort Study.
    Anticancer Res. 2020;40:5853-5860.
    PubMed     Abstract available
    
    
    
11. ANGELOU A, Papalois AE, Antoniou E, Wang J, et al
    The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated Cancer.
    Anticancer Res. 2020;40:5457-5462.
    PubMed     Abstract available
    
    
    
12. YIN F, Xie H, Lai J, Chen Y, et al
    Double Negativity for Expression of YAP1 and CDX2 Defines an Aggressive Type of Colitis-associated Cancer.
    Anticancer Res. 2020;40:5411-5416.
    PubMed     Abstract available
    
    
    
13. JIA JB, Ling X, Xing M, Ludwig JM, et al
    Novel TSPO-targeted Doxorubicin Prodrug for Colorectal Carcinoma Cells.
    Anticancer Res. 2020;40:5371-5378.
    PubMed     Abstract available
    
    
    September 2020
14. TAKAHASHI H, Takeda T, Nishizawa Y, Ogino T, et al
    Phase I Study of the Administration of Low-dose Perioperative Human Atrial Natriuretic Peptide in Patients With Resectable Colorectal Cancer.
    Anticancer Res. 2020;40:5301-5307.
    PubMed     Abstract available
    
    
    
15. NIKOLOVA B, Semkova S, Tsoneva I, Stoyanova E, et al
    Redox-related Molecular Mechanism of Sensitizing Colon Cancer Cells to Camptothecin Analog SN38.
    Anticancer Res. 2020;40:5159-5170.
    PubMed     Abstract available
    
    
    
16. MOZOLEWSKA P, Duzowska K, Pakiet A, Mika A, et al
    Inhibitors of Fatty Acid Synthesis and Oxidation as Potential Anticancer Agents in Colorectal Cancer Treatment.
    Anticancer Res. 2020;40:4843-4856.
    PubMed     Abstract available
    
    
    August 2020
17. YAMADA T, Yoshida Y, Maeda T, Yoshimatsu G, et al
    Changes in Immunological Status in Patients With Metastatic Colorectal Cancer Treated With First-line Chemoimmunotherapy.
    Anticancer Res. 2020;40:4763-4771.
    PubMed     Abstract available
    
    
    
18. NISHI K, Tsunoda T, Uchida Y, Sueta T, et al
    MK615 Suppresses Hypoxia Tolerance by Up-regulation of E-cadherin in Colorectal Cancer Cells With Mutant KRAS.
    Anticancer Res. 2020;40:4687-4694.
    PubMed     Abstract available
    
    
    
19. KUWATA GO, Ikeda K, Manome Y
    Involvement of Corticotropin-releasing Hormone-related Peptides in Cellular Stress Caused by Anticancer Drugs in Colorectal Cancer.
    Anticancer Res. 2020;40:4505-4511.
    PubMed     Abstract available
    
    
    
20. KIM BH, Oh HK, Kim DW, Kang SB, et al
    Clinical Implications of Cancer Stem Cell Markers and ABC Transporters as a Predictor of Prognosis in Colorectal Cancer Patients.
    Anticancer Res. 2020;40:4481-4489.
    PubMed     Abstract available
    
    
    
21. CHIKATANI K, Chika N, Suzuki O, Sakimoto T, et al
    A Model for Predicting DNA Mismatch Repair-deficient Colorectal Cancer.
    Anticancer Res. 2020;40:4379-4385.
    PubMed     Abstract available
    
    
    
22. WANG L, Hirano Y, Heng G, Ishii T, et al
    Better Cancer-specific Survival in Younger Patients With Stage III Colorectal Cancer: A Propensity Score Matching Study From Japan.
    Anticancer Res. 2020;40:4365-4372.
    PubMed     Abstract available
    
    
    
23. KEIKES L, Koopman M, Lemmens VEPP, VAN Oijen MGH, et al
    Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.
    Anticancer Res. 2020;40:4331-4341.
    PubMed     Abstract available
    
    
    
24. RAMOS-ESQUIVEL A, Chinchilla R, Valle M
    Association of C677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine-induced Toxicity in Mestizo Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2020;40:4263-4270.
    PubMed     Abstract available
    
    
    
25. NISHI K, Ishikura S, Umebayashi M, Morisaki T, et al
    Mutant KRAS Promotes NKG2D(+) T Cell Infiltration and CD155 Dependent Immune Evasion.
    Anticancer Res. 2020;40:4663-4674.
    PubMed     Abstract available
    
    
    
26. FIORI E, Crocetti D, Lamazza A, DE Felice F, et al
    Is Low Inferior Mesenteric Artery Ligation Worthwhile to Prevent Urinary and Sexual Dysfunction After Total Mesorectal Excision for Rectal Cancer?
    Anticancer Res. 2020;40:4223-4228.
    PubMed     Abstract available
    
    
    July 2020
27. SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
    Combining Bevacizumab With Trifluridine/Thymidine Phosphorylase Inhibitor Improves the Survival Outcomes Regardless of the Usage History of Bevacizumab in Front-line Treatment of Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2020;40:4157-4163.
    PubMed     Abstract available
    
    
    
28. POLITO R, Nigro E, Fei L, DE Magistris L, et al
    Adiponectin Is Inversely Associated With Tumour Grade in Colorectal Cancer Patients.
    Anticancer Res. 2020;40:3751-3757.
    PubMed     Abstract available
    
    
    
29. ENEH S, Heikkinen S, Hartikainen JM, Kuopio T, et al
    MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.
    Anticancer Res. 2020;40:3713-3722.
    PubMed     Abstract available
    
    
    
30. MEKLIN J, SyrjAnen K, Eskelinen M
    Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
    Anticancer Res. 2020;40:3591-3604.
    PubMed     Abstract available
    
    
    
31. IGUCHI T, Sugimachi K, Mano Y, Motomura T, et al
    Prognostic Impact of Geriatric Nutritional Risk Index in Patients With Synchronous Colorectal Liver Metastasis.
    Anticancer Res. 2020;40:4165-4171.
    PubMed     Abstract available
    
    
    
32. VIRGILIO E, Montali F, Costi R, Cavallini M, et al
    Proposal of a Classification System for Adenocarcinoma Involving the Ileocecal Valve (Bauhin's Valve): A Retrospective Study of 689 Right Hemicolectomized Patients.
    Anticancer Res. 2020;40:4053-4057.
    PubMed     Abstract available
    
    
    
33. CAO C, Parikh P, Moezardalan K, Anantharaman A, et al
    Synchronous Primary Pancreatic Ductal Carcinoma and Colonic Adenocarcinoma Present in a Patient With History of Skin Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:4029-4032.
    PubMed     Abstract available
    
    
    June 2020
34. SHIBUTANI M, Nakao S, Maeda K, Nagahara H, et al
    Inflammation Caused by Surgical Stress Has a Negative Impact on the Long-term Survival Outcomes in Patients With Colorectal Cancer.
    Anticancer Res. 2020;40:3535-3542.
    PubMed     Abstract available
    
    
    
35. MATSUDA A, Yamada T, Jamjittrong S, Shinji S, et al
    Comparison Between Biweekly and Weekly Cetuximab in Patients With Metastatic Colorectal Cancer: A Meta-analysis.
    Anticancer Res. 2020;40:3469-3476.
    PubMed     Abstract available
    
    
    
36. BAE KB, Kim SH, Kang MS, Kim DH, et al
    An Animal Model of Colorectal Cancer Liver Metastasis With a High Metastasis Rate and Clonal Dynamics.
    Anticancer Res. 2020;40:3297-3306.
    PubMed     Abstract available
    
    
    
37. TABCHOURI N, Eid Y, Manceau G, Frontali A, et al
    Neoadjuvant Treatment in Upper Rectal Cancer Does Not Improve Oncologic Outcomes But Increases Postoperative Morbidity.
    Anticancer Res. 2020;40:3579-3587.
    PubMed     Abstract available
    
    
    
38. ETO K, Kosuge M, Ohkuma M, Ito D, et al
    Umbilical Defunctioning Ileostomy for Rectal Cancer Results in Reduced Risk for Incisional Hernia.
    Anticancer Res. 2020;40:3445-3451.
    PubMed     Abstract available
    
    
    May 2020
39. FIORI E, Crocetti D, Lamazza A, DE Felice F, et al
    Defecatory Dysfunction After Colon Cancer Resection: The Role of Inferior Mesenteric Artery Tie.
    Anticancer Res. 2020;40:2969-2974.
    PubMed     Abstract available
    
    
    
40. ALMLOV K, Woisetschlager M, Loftas P, Hallbook O, et al
    MRI Lymph Node Evaluation for Prediction of Metastases in Rectal Cancer.
    Anticancer Res. 2020;40:2757-2763.
    PubMed     Abstract available
    
    
    
41. KOTNIK N, El-Sourani N, Raap U, Raab HR, et al
    Expression of MicroRNA in Locoregional Recurrent Rectal Cancer.
    Anticancer Res. 2020;40:2947-2953.
    PubMed     Abstract available
    
    
    April 2020
42. WATANABE D, Fujii H, Matsuhashi N, Iihara H, et al
    Dose Adjustment of Oxaliplatin Based on Renal Function in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2020;40:2379-2386.
    PubMed     Abstract available
    
    
    
43. ASHIZAWA N, Furuya S, Katsutoshi S, Sudo M, et al
    Clinical Significance of Dynamic Neutrophil-lymphocyte Ratio Changes in Patients With Colorectal Cancer.
    Anticancer Res. 2020;40:2311-2317.
    PubMed     Abstract available
    
    
    
44. HIGASHINO N, Matsuda T, Hasegawa H, Yamashita K, et al
    Outcomes of Laparoscopic Surgery in Colorectal Cancer Patients With Dialysis.
    Anticancer Res. 2020;40:2165-2170.
    PubMed     Abstract available
    
    
    
45. DE'ANGELIS N, Martinez-Perez A, Vitali GC, Pigneur F, et al
    Predicting Difficult Laparoscopic Total Mesorectal Excision for Locally-advanced Mid-low Rectal Cancer: The EuMaRCS Score Validation.
    Anticancer Res. 2020;40:2079-2087.
    PubMed     Abstract available
    
    
    
46. TOMORI K, Eto K, Haruki K, Sugano H, et al
    Comparison of Strength of Anastomosis Between Four Different Techniques for Colorectal Surgery.
    Anticancer Res. 2020;40:1891-1896.
    PubMed     Abstract available
    
    
    
47. NUMATA M, Kazama K, Onodera A, Hara K, et al
    Short-term Outcomes Following Robotic-assisted Laparoscopic Surgery for Technically Demanding Rectal Cancer.
    Anticancer Res. 2020;40:2337-2342.
    PubMed     Abstract available
    
    
    
48. HIRATA Y, Nozawa H, Kawai K, Hata K, et al
    The Influence of Neoadjuvant Chemoradiation for Middle and Lower Rectal Cancer on Anorectal Function.
    Anticancer Res. 2020;40:2199-2208.
    PubMed     Abstract available
    
    
    
49. KANG BH, Song C, Kang SB, Lee KW, et al
    Nomogram for Predicting the Pathological Tumor Response from Pre-treatment Clinical Characteristics in Rectal Cancer.
    Anticancer Res. 2020;40:2171-2177.
    PubMed     Abstract available
    
    
    March 2020
50. KOJIMA T, Hino H, Shiomi A, Kagawa H, et al
    Surgical Outcomes of Laparoscopic and Open D3 Dissection for Clinical Stage II/III Descending Colon Cancer.
    Anticancer Res. 2020;40:1731-1737.
    PubMed     Abstract available
    
    
    
51. WANG L, Hirano Y, Heng G, Ishii T, et al
    Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan.
    Anticancer Res. 2020;40:1651-1659.
    PubMed     Abstract available
    
    
    
52. KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
    Risk Benefit of FOLFIRI Plus Ramucirumab as Third-line and Later-line Treatment of Metastatic Colorectal Cancer.
    Anticancer Res. 2020;40:1605-1611.
    PubMed     Abstract available
    
    
    
53. KIM HJ, Han YS, Lee JH, Lee SH, et al
    Casein Kinase 2alpha Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress.
    Anticancer Res. 2020;40:1419-1426.
    PubMed     Abstract available
    
    
    
54. SARHADI V, Lahti L, Saberi F, Youssef O, et al
    Gut Microbiota and Host Gene Mutations in Colorectal Cancer Patients and Controls of Iranian and Finnish Origin.
    Anticancer Res. 2020;40:1325-1334.
    PubMed     Abstract available
    
    
    
55. HUNG YC, Chang WS, Chou AK, Pei JS, et al
    Association of Adiponectin Genotypes With Colorectal Cancer Susceptibility in Taiwan.
    Anticancer Res. 2020;40:1297-1306.
    PubMed     Abstract available
    
    
    
56. HURLEY PJ, Bose N, Jha G, Gargano M, et al
    Immunoglobulin Restores Immune Responses to BTH1677 in Patients With Low Levels of Antibodies to Beta-glucan.
    Anticancer Res. 2020;40:1467-1473.
    PubMed     Abstract available
    
    
    
57. NAUMANN DN, Ain Q, Evans CFM, Bajwa A, et al
    Factors Affecting Colorectal Polyp and Cancer Detection Rates in Patients Referred Urgently for Suspected Bowel Cancer.
    Anticancer Res. 2020;40:1705-1709.
    PubMed     Abstract available
    
    
    
58. PALKOVICS A, Vereczkei A, Fincsur A, Kiss I, et al
    Short- and Long-term Histological Changes in Liver Parenchyma After Different Resection Methods and Their Potential Role in Treatment of Colorectal Liver Metastasis.
    Anticancer Res. 2020;40:1359-1365.
    PubMed     Abstract available
    
    
    February 2020
59. YUN SH, Park JI
    COUP-TFII Overexpression Inhibits Cell Proliferation and Invasion via Increased Expression of p53 and PTEN and Decreased Akt Phosphorylation in Human Colorectal Cancer SNU-C4 Cells.
    Anticancer Res. 2020;40:767-777.
    PubMed     Abstract available
    
    
    
60. YUN SH, Park JI
    PGC-1alpha Regulates Cell Proliferation and Invasion via AKT/GSK-3beta/beta-catenin Pathway in Human Colorectal Cancer SW620 and SW480 Cells.
    Anticancer Res. 2020;40:653-664.
    PubMed     Abstract available
    
    
    
61. MEKLIN J, Syrjanen K, Eskelinen M
    Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests.
    Anticancer Res. 2020;40:575-581.
    PubMed     Abstract available
    
    
    
62. NAKAMOTO T, Hokuto D, Nomi T, Yoshikawa T, et al
    Characteristics of Five-year Survivors After Liver Resection for Colorectal Liver Metastases in Modern Chemotherapy.
    Anticancer Res. 2020;40:1107-1116.
    PubMed     Abstract available
    
    
    January 2020
63. RYU S, Suwa K, Kitagawa T, Aizawa M, et al
    Evaluation of Anastomosis With ICG Fluorescence Method Using VISERA ELITE2 During Laparoscopic Colorectal Cancer Surgery.
    Anticancer Res. 2020;40:373-377.
    PubMed     Abstract available
    
    
    
64. WATANABE D, Fujii H, Yamada Y, Iihara H, et al
    Relationship Between Renal Function and the Incidence of Adverse Events in Patients With Colorectal Cancer Receiving Oxaliplatin.
    Anticancer Res. 2020;40:299-304.
    PubMed     Abstract available
    
    
    
65. HAUS R, Janssen S, Schild SE, Rades D, et al
    A Disease-specific Score for Estimating Survival After Irradiation of Bone Metastases from Colorectal Cancer.
    Anticancer Res. 2020;40:287-291.
    PubMed     Abstract available
    
    
    
66. HIRABAYASHI S, Hayashi M, Nakayama G, Mii S, et al
    The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness.
    Anticancer Res. 2020;40:201-211.
    PubMed     Abstract available
    
    
    
67. YUN SH, Han SH, Park JI
    COUP-TFII Knock-down Promotes Proliferation and Invasion in Colorectal Cancer Cells via Activation of Akt Pathway and Up-regulation of FOXC1.
    Anticancer Res. 2020;40:177-190.
    PubMed     Abstract available
    
    
    
68. TANAKA T, Kobunai T, Yamamoto Y, Murono K, et al
    Assessment of the Changes in Mitochondrial Gene Polymorphism in Ulcerative Colitis and the Etiology of Ulcerative Colitis-associated Colorectal Cancer.
    Anticancer Res. 2020;40:101-107.
    PubMed     Abstract available
    
    
    
69. OKUYAMA H, Nogami W, Sato Y, Yoshida H, et al
    Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells.
    Anticancer Res. 2020;40:169-176.
    PubMed     Abstract available
    
    
    
70. DORR NM, Bartels M, Morgul MH
    Current Treatment of Colorectal Liver Metastasis as a Chronic Disease.
    Anticancer Res. 2020;40:1-7.
    PubMed     Abstract available
    
    
    December 2019
71. TANAKA H, Kawaguchi M, Shoda S, Miyoshi T, et al
    Nuclear Accumulation of beta-Catenin in Cancer Stem Cell Radioresistance and Stemness in Human Colon Cancer.
    Anticancer Res. 2019;39:6575-6583.
    PubMed     Abstract available
    
    
    
72. WU MH, Tzeng HE, Wu CN, Yueh TC, et al
    Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk.
    Anticancer Res. 2019;39:6523-6529.
    PubMed     Abstract available
    
    
    
73. ZHU G, Zhao M, Han Q, Tan Y, et al
    Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model.
    Anticancer Res. 2019;39:6463-6470.
    PubMed     Abstract available
    
    
    
74. OGINO Y, Sato A, Kawano Y, Aoyama T, et al
    Association of ABC Transporter With Resistance to FK866, a NAMPT Inhibitor, in Human Colorectal Cancer Cells.
    Anticancer Res. 2019;39:6457-6462.
    PubMed     Abstract available
    
    
    
75. PETRELLI F, Ghidini M, Cabiddu M, Pezzica E, et al
    Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis.
    Anticancer Res. 2019;39:6431-6441.
    PubMed     Abstract available
    
    
    
76. DE FELICE F, Siniscalchi B, Bulzonetti N, Caiazzo R, et al
    Tolerability of Oxaliplatin-based Neoadjuvant Chemoradiotherapy in Elderly Locally Advanced Rectal Cancer Patients: A Case-control Study of a Real-life Experience.
    Anticancer Res. 2019;39:6957-6963.
    PubMed     Abstract available
    
    
    
77. FIORI E, Crocetti D, Lamazza A, DE Felice F, et al
    Resection or Stenting in the Treatment of Symptomatic Advanced Metastatic Rectal Cancer: A Dilemma.
    Anticancer Res. 2019;39:6781-6786.
    PubMed     Abstract available
    
    
    
78. CIZMARIKOVA M, Takac P, Spengler G, Kincses A, et al
    New Chalcone Derivative Inhibits ABCB1 in Multidrug Resistant T-cell Lymphoma and Colon Adenocarcinoma Cells.
    Anticancer Res. 2019;39:6499-6505.
    PubMed     Abstract available
    
    
    
79. SOHN M, Agha A, Trum S, Moser C, et al
    Frequency of Polyps and Adenocarcinoma in Colon Interposition After Esophagectomy in Adulthood - A Systematic Review.
    Anticancer Res. 2019;39:6419-6430.
    PubMed     Abstract available
    
    
    November 2019
80. KAYANO H, Nomura E, Ueda Y, Kuramoto T, et al
    Short- and Long-term Outcomes of 2-Step Stapled Intracorporeal Versus Extracorporeal Anastomosis in Laparoscopic Colectomy for Colon Cancer.
    Anticancer Res. 2019;39:6393-6401.
    PubMed     Abstract available
    
    
    
81. KATAFYGIOTIS P, Sakellariou S, Chatziandreou I, Giannopoulou I, et al
    Microsatellite Instability in Greek Colorectal Carcinoma Patients: Clinicopathological and Molecular Correlations.
    Anticancer Res. 2019;39:6379-6387.
    PubMed     Abstract available
    
    
    
82. HORIUCHI T, Haruki K, Shiba H, Sakamoto T, et al
    Assessment of Outcome of Hepatic Resection for Extremely Elderly Patients With a Hepatic Malignancy.
    Anticancer Res. 2019;39:6325-6332.
    PubMed     Abstract available
    
    
    
83. HO ML, Kuo WK, Chu LJ, Yeh IH, et al
    N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies.
    Anticancer Res. 2019;39:6317-6324.
    PubMed     Abstract available
    
    
    
84. PALAIOLOGOS P, Chrysikos D, Theocharis S, Kouraklis G, et al
    The Prognostic Value of G1 Cyclins, p21 and Rb Protein in Patients With Colon Cancer.
    Anticancer Res. 2019;39:6291-6297.
    PubMed     Abstract available
    
    
    
85. TREDER M, Janssen S, Schild SE, Rades D, et al
    Results of Tri-Modality Therapy for Rectal Cancer in Elderly Patients.
    Anticancer Res. 2019;39:6217-6222.
    PubMed     Abstract available
    
    
    
86. WU CC, Lai PY, Hsieh S, Cheng CC, et al
    Suppression of Carnosine on Adhesion and Extravasation of Human Colorectal Cancer Cells.
    Anticancer Res. 2019;39:6135-6144.
    PubMed     Abstract available
    
    
    
87. CHANDIMALI N, Sun HN, Kong LZ, Zhen X, et al
    Shikonin-induced Apoptosis of Colon Cancer Cells Is Reduced by Peroxiredoxin V Expression.
    Anticancer Res. 2019;39:6115-6123.
    PubMed     Abstract available
    
    
    
88. KIM HB, Lim HJ, Lee HJ, Park JH, et al
    Evaluation and Clinical Significance of Jagged-1-activated Notch Signaling by APEX1 in Colorectal Cancer.
    Anticancer Res. 2019;39:6097-6105.
    PubMed     Abstract available
    
    
    
89. VYCITAL O, Pitule P, Hosek P, Kriz T, et al
    Expression of Serpin B9 as a Prognostic Factor of Colorectal Cancer.
    Anticancer Res. 2019;39:6063-6066.
    PubMed     Abstract available
    
    
    
90. BUNDSCHERER AC, Ullrich V, Malsy M, Gruber MA, et al
    Effects of Volatile Anesthetics on Proliferation and Viability of SW480 Colon Cancer Cells In Vitro.
    Anticancer Res. 2019;39:6049-6055.
    PubMed     Abstract available
    
    
    
91. ZHU G, Zhao M, Han Q, Tan Y, et al
    Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model.
    Anticancer Res. 2019;39:5999-6005.
    PubMed     Abstract available
    
    
    
92. LEHTOMAKI KI, Lahtinen LI, Rintanen N, Kuopio T, et al
    Clonal Evolution of MEK/MAPK Pathway Activating Mutations in a Metastatic Colorectal Cancer Case.
    Anticancer Res. 2019;39:5867-5877.
    PubMed     Abstract available
    
    
    
93. CUMBO M, Tomic B, Dunjic S, Jovanovic T, et al
    Prothrombin 3'end Gene Variants in Patients With Sporadic Colon Adenocarcinoma.
    Anticancer Res. 2019;39:6067-6071.
    PubMed     Abstract available
    
    
    October 2019
94. NEKI K, Eto K, Kosuge M, Ohkuma M, et al
    Identification of the Risk Factors for Recurrence of Stage III Colorectal Cancer.
    Anticancer Res. 2019;39:5721-5724.
    PubMed     Abstract available
    
    
    
95. FIALA O, Ostasov P, Hosek P, Sorejs O, et al
    The Predictive Role of Primary Tumour Sidedness in Metastatic Colorectal Cancer Treated With Targeted Agents.
    Anticancer Res. 2019;39:5645-5652.
    PubMed     Abstract available
    
    
    
96. QIU Z, Andrijauskaite K, Morris J, Wargovich MJ, et al
    Disruption of Epigenetic Silencing in Human Colon Cancer Cells Lines Utilizing a Novel Supercritical CO2 Extract of Neem Leaf (Azadirachta indica).
    Anticancer Res. 2019;39:5473-5481.
    PubMed     Abstract available
    
    
    
97. UETA K, Matsuda T, Yamashita K, Hasegawa H, et al
    Treatment Strategy for Rectal Cancer Patients With Inguinal Lymph Node Metastasis.
    Anticancer Res. 2019;39:5767-5772.
    PubMed     Abstract available
    
    
    
98. SHIBUYA N, Matsuda T, Yamashita K, Hasegawa H, et al
    Clinical Significance of Intraoperative Colonoscopy for Anastomotic Assessment in Rectal Cancer Surgery.
    Anticancer Res. 2019;39:5761-5765.
    PubMed     Abstract available
    
    
    September 2019
99. SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
    Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Anticancer Res. 2019;39:5039-5045.
    PubMed     Abstract available
    
    
    
100. DIMBERG J, Shamoun L, Landerholm K, Andersson RE, et al
     Genetic Variants of the IL2 Gene Related to Risk and Survival in Patients With Colorectal Cancer.
     Anticancer Res. 2019;39:4933-4940.
     PubMed     Abstract available
     
     
     
101. SIGNORELLI C, Chilelli MG, Sperduti I, Giacinti S, et al
     Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis.
     Anticancer Res. 2019;39:4917-4924.
     PubMed     Abstract available
     
     
     
102. SEATON ME, Peters U, Johnson KC, Kooperberg C, et al
     Effects of Colorectal Cancer Risk Factors on the Association Between Aspirin and Colorectal Cancer.
     Anticancer Res. 2019;39:4877-4884.
     PubMed     Abstract available
     
     
     
103. YUN CW, Lee JH, Lee SH
     Hypoxia-induced PGC-1alpha Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer Cells.
     Anticancer Res. 2019;39:4865-4876.
     PubMed     Abstract available
     
     
     
104. HA YJ, Tak KH, Kim SK, Kim CW, et al
     Biological Characteristics and Clinical Significance of ITGB1 and RHOC in Patients With Recurrent Colorectal Cancer.
     Anticancer Res. 2019;39:4853-4864.
     PubMed     Abstract available
     
     
     
105. KURAMOCHI H, Nakajima GO, Hayashi K, Araida T, et al
     Amphiregulin/epiregulin mRNA Expression and Primary Tumor Location in Colorectal Cancer.
     Anticancer Res. 2019;39:4729-4736.
     PubMed     Abstract available
     
     
     
106. OSHIRO H, Tome Y, Kiyuna T, Yoon SN, et al
     Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.
     Anticancer Res. 2019;39:4667-4671.
     PubMed     Abstract available
     
     
     
107. OHARA T, Mori T
     Antiproliferative Effects of Short-chain Fatty Acids on Human Colorectal Cancer Cells via Gene Expression Inhibition.
     Anticancer Res. 2019;39:4659-4666.
     PubMed     Abstract available
     
     
     
108. FUKUOKA T, Maeda K, Nagahara H, Shibutani M, et al
     Change in PMI During Neoadjuvant Therapy Is a Predictive Prognostic Marker in Rectal Cancer.
     Anticancer Res. 2019;39:5157-5163.
     PubMed     Abstract available
     
     
     
109. ISKANDER O, Courtot L, Tabchouri N, Artus A, et al
     Complete Pathological Response Following Radiochemotherapy for Locally Advanced Rectal Cancer: Short and Long-term Outcome.
     Anticancer Res. 2019;39:5105-5113.
     PubMed     Abstract available
     
     
     
110. KOMORI K, Kinoshita T, Oshiro T, Ouchi A, et al
     Surgical Strategy for Rectovaginal Fistula After Colorectal Anastomosis at a High-volume Cancer Center According to Image Type and Colonoscopy Findings.
     Anticancer Res. 2019;39:5097-5103.
     PubMed     Abstract available
     
     
     
111. MORINE Y, Ikemoto T, Iwahashi S, Saito YU, et al
     Clinical Impact of FOLFOXIRI Aiming for Conversion Surgery in Unresectable Multiple Colorectal Liver Metastasis.
     Anticancer Res. 2019;39:5089-5096.
     PubMed     Abstract available
     
     
     
112. RUBIO CA, Schmidt PT
     The Normal Epithelium of Crypts Accruing Below Nonpolypoid Adenomas Thrives With Relocated Proliferating Cell-domains and p53-Up-regulated Cells.
     Anticancer Res. 2019;39:4965-4970.
     PubMed     Abstract available
     
     
     
113. LUCERI C, Femia AP, D'Ambrosio M, Caderni G, et al
     High Sensitivity to Cholic Acid-induced Colonic Tumorigenesis Makes Female PIRC Rats (F344/NTac-Apc(am1137)) a Suitable Model for Studying CRC-promoting Agents.
     Anticancer Res. 2019;39:4673-4679.
     PubMed     Abstract available
     
     
     August 2019
114. HISAKA T, Ishikawa H, Sakai H, Kawahara R, et al
     Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver Metastasis.
     Anticancer Res. 2019;39:4549-4554.
     PubMed     Abstract available
     
     
     
115. TAKIMOTO R, Kamigaki T, Okada S, Matsuda E, et al
     Prognostic Factors for Colorectal Cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study.
     Anticancer Res. 2019;39:4525-4532.
     PubMed     Abstract available
     
     
     
116. ASHIZAWA N, Shimizu H, Sudo M, Furuya S, et al
     Clinical Significance of NADPH Oxidase 5 in Human Colon Cancer.
     Anticancer Res. 2019;39:4405-4410.
     PubMed     Abstract available
     
     
     
117. MATSUDA A, Yamada T, Matsumoto S, Sakurazawa N, et al
     Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival After TAS-102 Treatment of Patients With Metastatic Colorectal Cancer.
     Anticancer Res. 2019;39:4343-4350.
     PubMed     Abstract available
     
     
     
118. ITO Y, Kobuchi S, Takesada W, Takahashi C, et al
     Assessment of Oxaliplatin-induced Chronic Neuropathy and Anticancer Efficacy Through Pharmacokinetic and Toxicodynamic Evaluation of a Rat Model of Colorectal Cancer.
     Anticancer Res. 2019;39:4207-4213.
     PubMed     Abstract available
     
     
     
119. YOON SN, Park JH, Lwin TM, Miyake K, et al
     Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis.
     Anticancer Res. 2019;39:4065-4071.
     PubMed     Abstract available
     
     
     
120. NAYERI M, Iskander O, Tabchouri N, Artus A, et al
     Low Tie Compared to High Tie Vascular Ligation of the Inferior Mesenteric Artery in Rectal Cancer Surgery Decreases Postoperative Complications Without Affecting Overall Survival.
     Anticancer Res. 2019;39:4363-4370.
     PubMed     Abstract available
     
     
     
121. RUBIO CA, Schmidt PT
     Dissecting the Microscopic Anatomy of Colon Crypts in Non-dysplastic Sessile Serrated Polyps.
     Anticancer Res. 2019;39:4259-4263.
     PubMed     Abstract available
     
     
     July 2019
122. GIULIANI J, Bonetti A
     The Onset of Grade >/=3 Neutropenia Is Associated With Longer Overall Survival in Metastatic Colorectal Cancer Patients Treated With Trifluridine/Tipiracil.
     Anticancer Res. 2019;39:3967-3969.
     PubMed     Abstract available
     
     
     
123. CZUMAJ A, Zabielska J, Pakiet A, Mika A, et al
     In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation.
     Anticancer Res. 2019;39:3815-3822.
     PubMed     Abstract available
     
     
     
124. LIU Y, Kwon T, Kim JS, Chandimali N, et al
     Peroxiredoxin V Reduces beta-Lapachone-induced Apoptosis of Colon Cancer Cells.
     Anticancer Res. 2019;39:3677-3686.
     PubMed     Abstract available
     
     
     
125. KIM JY, Park G, Krishnan M, Ha E, et al
     Selective Wnt/beta-catenin Small-molecule Inhibitor CWP232228 Impairs Tumor Growth of Colon Cancer.
     Anticancer Res. 2019;39:3661-3667.
     PubMed     Abstract available
     
     
     
126. KOBUNAI T, Matsuoka K, Takechi T
     ChIP-seq Analysis to Explore DNA Replication Profile in Trifluridine-treated Human Colorectal Cancer Cells In Vitro.
     Anticancer Res. 2019;39:3565-3570.
     PubMed     Abstract available
     
     
     
127. PARK JH, Zhao M, Oshiro H, Miyake K, et al
     Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells.
     Anticancer Res. 2019;39:3463-3467.
     PubMed     Abstract available
     
     
     
128. VUJIC J, Schollnast H, Marsoner K, Wienerroither V, et al
     Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy via CT - A Pilot Study.
     Anticancer Res. 2019;39:3847-3854.
     PubMed     Abstract available
     
     
     
129. PATTAYIL L, Balakrishnan-Saraswathi HT
     In Vitro Evaluation of Apoptotic Induction of Butyric Acid Derivatives in Colorectal Carcinoma Cells.
     Anticancer Res. 2019;39:3795-3801.
     PubMed     Abstract available
     
     
     June 2019
130. ETO S, Kawahara H, Matsumoto T, Hirabayashi T, et al
     Preoperative Neutrophil-Lymphocyte Ratio Is a Predictor of Bowel Obstruction Due to Colorectal Cancer Growth.
     Anticancer Res. 2019;39:3185-3189.
     PubMed     Abstract available
     
     
     
131. VIRGILIO E, Balducci G, Mercantini P, Ferri M, et al
     Curative and Prophylactic Surgery of Young-onset Colorectal Cancer in Inherited Syndromes: A 15-Year Monocentric Retrospective Experience.
     Anticancer Res. 2019;39:3131-3136.
     PubMed     Abstract available
     
     
     
132. MOKKARALA M, Noda C, Malone C, Ramaswamy R, et al
     Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE) Versus Radioembolization (TARE) for Patients With Colorectal Cancer Liver Metastases.
     Anticancer Res. 2019;39:3071-3077.
     PubMed     Abstract available
     
     
     
133. RYU S, Suwa K, Kitagawa T, Aizawa M, et al
     Real-Time Fluorescence Vessel Navigation Using Indocyanine Green During Laparoscopic Colorectal Cancer Surgery.
     Anticancer Res. 2019;39:3009-3013.
     PubMed     Abstract available
     
     
     
134. ISHIKAWA D, Takasu C, Kashihara H, Nishi M, et al
     The Significance of MicroRNA-449a and Its Potential Target HDAC1 in Patients With Colorectal Cancer.
     Anticancer Res. 2019;39:2855-2860.
     PubMed     Abstract available
     
     
     
135. WU MH, Hung YW, Gong CL, Chao CC, et al
     Contribution of Caspase-8 Genotypes to Colorectal Cancer Risk in Taiwan.
     Anticancer Res. 2019;39:2791-2797.
     PubMed     Abstract available
     
     
     
136. GZIL A, Szylberg L, Jaworski D, Dominiak J, et al
     The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
     Anticancer Res. 2019;39:2689-2697.
     PubMed     Abstract available
     
     
     
137. JUNGINGER T, Goenner U, Trinh TT, Heintz A, et al
     The Link Between Local Recurrence and Distant Metastases in Patients With Rectal Cancer.
     Anticancer Res. 2019;39:3079-3088.
     PubMed     Abstract available
     
     
     
138. TAKEDA M, Kawahara H, Ogawa M, Suwa K, et al
     Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study.
     Anticancer Res. 2019;39:3047-3052.
     PubMed     Abstract available
     
     
     
139. PALUMBO P, Usai S, Pansa A, Lucchese S, et al
     Anastomotic Leakage in Rectal Surgery: Role of the Ghost Ileostomy.
     Anticancer Res. 2019;39:2975-2983.
     PubMed     Abstract available
     
     
     
140. YOON G, Park JY, Kim HJ, Choi GS, et al
     ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.
     Anticancer Res. 2019;39:2845-2853.
     PubMed     Abstract available
     
     
     
141. TANIYAMA D, Taniyama K, Kuraoka K, Yamamoto H, et al
     CD204-Positive Tumor-associated Macrophages Relate to Malignant Transformation of Colorectal Adenoma.
     Anticancer Res. 2019;39:2767-2775.
     PubMed     Abstract available
     
     
     May 2019
142. RADES D, Hansen HC, Janssen S, Schild SE, et al
     Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer.
     Anticancer Res. 2019;39:2569-2574.
     PubMed     Abstract available
     
     
     
143. OGAWA H, Kaira K, Motegi Y, Yokobori T, et al
     Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.
     Anticancer Res. 2019;39:2535-2543.
     PubMed     Abstract available
     
     
     
144. ANGELOU A, Antoniou E, Pikouli A, Wang J, et al
     Platelet Depletion/Transfusion as a Lethal Factor in a Colitis-associated Cancer Mouse Model.
     Anticancer Res. 2019;39:2443-2446.
     PubMed     Abstract available
     
     
     
145. MANTSO T, Vasileiadis S, Lampri E, Botaitis S, et al
     Hyperthermia Suppresses Post - In Vitro Proliferation and Tumor Growth in Murine Malignant Melanoma and Colon Carcinoma.
     Anticancer Res. 2019;39:2307-2315.
     PubMed     Abstract available
     
     
     April 2019
146. RALLIS G, Koletsa T, Saridaki Z, Manousou K, et al
     Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer.
     Anticancer Res. 2019;39:2129-2138.
     PubMed     Abstract available
     
     
     
147. HAMADA K, Otsubo R, Takeshita H, Nonaka T, et al
     Diagnosis of Lymph Node Metastasis in Colorectal Cancer by a Semi-dry Dot-blot Method.
     Anticancer Res. 2019;39:2069-2076.
     PubMed     Abstract available
     
     
     
148. BENDARDAF R, Sharif-Askari FS, Sharif-Askari NS, Syrjanen K, et al
     Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer.
     Anticancer Res. 2019;39:1953-1957.
     PubMed     Abstract available
     
     
     
149. ALAGARATNAM S, Yang SY, Loizidou M, Fuller B, et al
     Mechano-growth Factor Expression in Colorectal Cancer Investigated With Fluorescent Gold Nanoparticles.
     Anticancer Res. 2019;39:1705-1710.
     PubMed     Abstract available
     
     
     
150. FRANSGAARD T, Hallas J, Thygesen LC, Gogenur I, et al
     Association of Statin Use and Oncological Outcomes After Neoadjuvant Radiotherapy in Patients With Rectal Cancer.
     Anticancer Res. 2019;39:2177-2182.
     PubMed     Abstract available
     
     
     
151. PETRUCCIANI N, Carra MC, Martinez-Perez A, Vitali GC, et al
     Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
     Anticancer Res. 2019;39:2113-2120.
     PubMed     Abstract available
     
     
     
152. SADAHIRO S, Suzuki T, Tanaka A, Okada K, et al
     Induction of CD3+ and FoxP3+ T Cells in Left-sided Colorectal Tumors After UFT/LV Chemotherapy.
     Anticancer Res. 2019;39:1997-2005.
     PubMed     Abstract available
     
     
     
153. PINELLI A, Ferrario P, Trivulzio S
     Preliminary Observation on the Cytotoxic Activity of New Chlorophyllin Derivative RCD on Human Tumour Cell Lines In Vitro.
     Anticancer Res. 2019;39:1807-1812.
     PubMed     Abstract available
     
     
     
154. OSMAN J, Bellamkonda K, Liu Q, Andersson T, et al
     The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
     Anticancer Res. 2019;39:1719-1728.
     PubMed     Abstract available
     
     
     March 2019
155. ARAKAWA K, Hata K, Nozawa H, Kawai K, et al
     Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients.
     Anticancer Res. 2019;39:1425-1432.
     PubMed     Abstract available
     
     
     
156. NAGATA T, Fukuda KI, Tamai M, Taniguchi A, et al
     Early Neuropathy Related to Oxaliplatin Treatment in Advanced and Recurrent Colorectal Cancer.
     Anticancer Res. 2019;39:1347-1353.
     PubMed     Abstract available
     
     
     
157. YANO Y, Yoshimatsu K, Yokomizo H, Sagawa M, et al
     Enhancement of the Marginal Area in Colorectal Cancer Liver Metastasis on Computed Tomography Correlates With Microvessel Density and Clinicopathological Factors.
     Anticancer Res. 2019;39:1301-1308.
     PubMed     Abstract available
     
     
     
158. LI CC, Liang JA, Chung CY, Chen WT, et al
     Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis.
     Anticancer Res. 2019;39:1479-1484.
     PubMed     Abstract available
     
     
     
159. HANSEN HC, Janssen S, Thieme C, Perlov A, et al
     Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses.
     Anticancer Res. 2019;39:1343-1346.
     PubMed     Abstract available
     
     
     
160. REZNICZEK GA, Grunwald C, Hilal Z, Scheich J, et al
     ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin).
     Anticancer Res. 2019;39:1267-1273.
     PubMed     Abstract available
     
     
     February 2019
161. YAMAMOTO M, Saito H, Uejima C, Tanio A, et al
     Combination of Serum Albumin and Cholinesterase Levels as Prognostic Indicator in Patients ith Colorectal Cancer.
     Anticancer Res. 2019;39:1085-1090.
     PubMed     Abstract available
     
     
     
162. SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
     Prognostic Significance of the C-Reactive Protein-to-Albumin Ratio in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Thymidine Phosphorylase Inhibitor as Later-line Chemotherapy.
     Anticancer Res. 2019;39:1051-1057.
     PubMed     Abstract available
     
     
     
163. KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
     Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer.
     Anticancer Res. 2019;39:1029-1034.
     PubMed     Abstract available
     
     
     
164. SMOLLE MA, Kashofer K, Riedl JM, Stotz M, et al
     Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature.
     Anticancer Res. 2019;39:847-852.
     PubMed     Abstract available
     
     
     
165. SRODA-POMIANEK K, Michalak K, Palko-Labuz A, Uryga A, et al
     Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells.
     Anticancer Res. 2019;39:727-734.
     PubMed     Abstract available
     
     
     
166. BAE GE, DO SI, Kim K, Park JH, et al
     Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.
     Anticancer Res. 2019;39:663-670.
     PubMed     Abstract available
     
     
     
167. LEE D, Matsuda T, Yamashita K, Hasegawa H, et al
     Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer.
     Anticancer Res. 2019;39:993-998.
     PubMed     Abstract available
     
     
     
168. RUBIO CA, Schmidt PT
     Crypts With Corrupted Shapes in Non-polypoid Adenomas.
     Anticancer Res. 2019;39:833-838.
     PubMed     Abstract available
     
     
     
169. OZTOP S, Isik A, Guner G, Gurdal H, et al
     Class III beta-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response.
     Anticancer Res. 2019;39:655-662.
     PubMed     Abstract available
     
     
     January 2019
170. KEARNEY MR, Chen EY, Vaccaro GM, Strother J, et al
     A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer.
     Anticancer Res. 2019;39:245-252.
     PubMed     Abstract available
     
     
     
171. SHIMIZU D, Masuda T, Sato K, Tsuruda Y, et al
     CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis.
     Anticancer Res. 2019;39:99-106.
     PubMed     Abstract available
     
     
     
172. KUDOU M, Arita T, Nakanishi M, Kuriu Y, et al
     Essentiality of Imaging Diagnostic Criteria Specific to Rectal Neuroendocrine Tumors for Detecting Metastatic Lymph Nodes.
     Anticancer Res. 2019;39:505-510.
     PubMed     Abstract available
     
     
     
173. GUIMARAES DP, Fregnani JH, Reis RM, Taveira LN, et al
     Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
     Anticancer Res. 2019;39:261-269.
     PubMed     Abstract available
     
     
     
174. WAKUI M, Kawai K, Mizushima T, Nishime C, et al
     Fatty Acid beta-Oxidation-dependent and -independent Responses and Tumor Aggressiveness Acquired Under Mild Hypoxia.
     Anticancer Res. 2019;39:191-200.
     PubMed     Abstract available
     
     
     
175. MUTO Y, Furihata T, Kaneko M, Higuchi K, et al
     Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203.
     Anticancer Res. 2019;39:159-165.
     PubMed     Abstract available
     
     
     
176. GUDUR A, Shanmuganandamurthy D, Szep Z, Poggio JL, et al
     An Update on the Current Role of High Resolution Anoscopy in Patients With Anal Dysplasia.
     Anticancer Res. 2019;39:17-23.
     PubMed     Abstract available
     
     
     December 2018
177. SHIBUYA N, Ishizuka M, Takagi K, Iwasaki Y, et al
     Relationship Between Preoperative Erythrocyte Sedimentation Rate and Survival After Surgery in Patients with Colorectal Cancer.
     Anticancer Res. 2018;38:6783-6788.
     PubMed     Abstract available
     
     
     
178. MATSUTANI S, Shibutani M, Maeda K, Nagahara H, et al
     Tumor-infiltrating Immune Cells in H&E-stained Sections of Colorectal Cancer Tissue as a Reasonable Immunological Biomarker.
     Anticancer Res. 2018;38:6721-6727.
     PubMed     Abstract available
     
     
     
179. KOH HK, Kim K, Jang WI, Song CH, et al
     Radiation Therapy for Anal Squamous Cell Carcinoma: A Retrospective Multicenter Study.
     Anticancer Res. 2018;38:6931-6938.
     PubMed     Abstract available
     
     
     
180. LEE JH, Song C, Kang SB, Lee HS, et al
     Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
     Anticancer Res. 2018;38:6905-6910.
     PubMed     Abstract available
     
     
     
181. KIM J, Ahn S, Kim K, Cho MS, et al
     Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
     Anticancer Res. 2018;38:6881-6889.
     PubMed     Abstract available
     
     
     
182. RADES D, Vogelsang RP, Treder M, Janssen S, et al
     A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers.
     Anticancer Res. 2018;38:6877-6880.
     PubMed     Abstract available
     
     
     
183. MORELLI C, Formica V, Pellicori S, Menghi A, et al
     Chemotherapy in Patients with Hereditary Angioedema.
     Anticancer Res. 2018;38:6801-6807.
     PubMed     Abstract available
     
     
     November 2018
184. BENDARDAF R, Sharif-Askari FS, Sharif-Askari NS, Syrjanen K, et al
     Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen.
     Anticancer Res. 2018;38:6399-6404.
     PubMed     Abstract available
     
     
     
185. MASUDA T, Margonis GA, Andreatos N, Wang J, et al
     Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of Tumors.
     Anticancer Res. 2018;38:6353-6360.
     PubMed     Abstract available
     
     
     
186. ENKHBAT T, Nishi M, Yoshikawa K, Jun H, et al
     Epigallocatechin-3-gallate Enhances Radiation Sensitivity in Colorectal Cancer Cells Through Nrf2 Activation and Autophagy.
     Anticancer Res. 2018;38:6247-6252.
     PubMed     Abstract available
     
     
     
187. DA SILVA MACHADO F, Munari FM, Scariot FJ, Echeverrigaray S, et al
     Piperlongumine Induces Apoptosis in Colorectal Cancer HCT 116 Cells Independent of Bax, p21 and p53 Status.
     Anticancer Res. 2018;38:6231-6236.
     PubMed     Abstract available
     
     
     
188. SUEHIRO Y, Takemoto Y, Nishimoto A, Ueno K, et al
     Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer.
     Anticancer Res. 2018;38:6225-6230.
     PubMed     Abstract available
     
     
     
189. SEMAAN C, Neilson KA, Brown B, Molloy MP, et al
     Pharmacological Inhibition of Casein Kinase 2 Enhances the Effectiveness of PI3K Inhibition in Colon Cancer Cells.
     Anticancer Res. 2018;38:6195-6200.
     PubMed     Abstract available
     
     
     
190. NAKURTE I, Jekabsons K, Rembergs R, Zandberga E, et al
     Colorectal Cancer Cell Line SW480 and SW620 Released Extravascular Vesicles: Focus on Hypoxia-induced Surface Proteome Changes.
     Anticancer Res. 2018;38:6133-6138.
     PubMed     Abstract available
     
     
     
191. WANG B, Ogata H, Takishima Y, Miyamoto S, et al
     A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11.
     Anticancer Res. 2018;38:6121-6126.
     PubMed     Abstract available
     
     
     
192. MASUISHI T, Taniguchi H, Eto T, Komori A, et al
     Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases.
     Anticancer Res. 2018;38:6501-6506.
     PubMed     Abstract available
     
     
     
193. PALKOVICS A, Vereczkei A, Kalmar KN, Fincsur A, et al
     The Issue of Survival After Colorectal Liver Metastasis Surgery: Parenchyma Sparing vs. Radicality.
     Anticancer Res. 2018;38:6431-6438.
     PubMed     Abstract available
     
     
     October 2018
194. KAMIZA AB, Wang WC, You JF, Tang R, et al
     EGFR, SMAD7, and TGFBR2 Polymorphisms Are Associated with Colorectal Cancer in Patients with Lynch Syndrome.
     Anticancer Res. 2018;38:5983-5990.
     PubMed     Abstract available
     
     
     
195. ARAKAWA K, Hata K, Nozawa H, Kawai K, et al
     Prognostic Significance and Clinicopathological Features of Synchronous Colorectal Cancer.
     Anticancer Res. 2018;38:5889-5895.
     PubMed     Abstract available
     
     
     
196. KIM JN, Kim TH, Yoon JH, Cho SG, et al
     Kisspeptin Inhibits Colorectal Cancer Cell Invasiveness by Activating PKR and PP2A.
     Anticancer Res. 2018;38:5791-5798.
     PubMed     Abstract available
     
     
     
197. SINGH B, Singh G, Pourgholami M, Alzahrani N, et al
     Long-term Survival and Propensity Score Matched Outcomes of Bilateral vs. Unilateral Diaphragm Interventions in Cytoreductive Surgery plus Intra-peritoneal Chemotherapy.
     Anticancer Res. 2018;38:5917-5921.
     PubMed     Abstract available
     
     
     
198. MURATA H, Okamoto M, Takahashi T, Motegi M, et al
     SUVmax-based Parameters of FDG-PET/CT Reliably Predict Pathologic Complete Response After Preoperative Hyperthermo-chemoradiotherapy in Rectal Cancer.
     Anticancer Res. 2018;38:5909-5916.
     PubMed     Abstract available
     
     
     
199. DE CESARE M
     High Efficacy of Intravenous Gimatecan on Human Tumor Xenografts.
     Anticancer Res. 2018;38:5783-5790.
     PubMed     Abstract available
     
     
     
200. AKAMINE T, Morodomi Y, Harada Y, Teraishi K, et al
     miR-3148 Is a Novel Onco-microRNA that Potentiates Tumor Growth In Vivo.
     Anticancer Res. 2018;38:5693-5701.
     PubMed     Abstract available
     
     
     September 2018
201. JORDAN F, Grundmann N, Schenkirsch G, Markl B, et al
     Impact of Primary Tumor Localization on the Efficacy of Bevacizumab in Metastatic Colorectal Cancer.
     Anticancer Res. 2018;38:5539-5546.
     PubMed     Abstract available
     
     
     
202. KAWAHARA H, Yoshida S, Tohyama Y, Yanagisawa S, et al
     Serum Carcinoembryonic Antigen Levels Before the First Curative Hepatectomy for Metastatic Colorectal Cancer Is a Predictor of Recurrence.
     Anticancer Res. 2018;38:5351-5355.
     PubMed     Abstract available
     
     
     
203. ENDZELINS E, Abols A, Buss A, Zandberga E, et al
     Extracellular Vesicles Derived from Hypoxic Colorectal Cancer Cells Confer Metastatic Phenotype to Non-metastatic Cancer Cells.
     Anticancer Res. 2018;38:5139-5147.
     PubMed     Abstract available
     
     
     
204. LEA MA, Kim H, desBORDES C
     Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells.
     Anticancer Res. 2018;38:5003-5011.
     PubMed     Abstract available
     
     
     
205. TRESKA V, Fichtl J, Ludvik J, Bruha J, et al
     Portal Vein Embolization (PVE) Versus PVE with Haematopoietic Stem Cell Application in Patients with Primarily Non-resectable Colorectal Liver Metastases.
     Anticancer Res. 2018;38:5531-5537.
     PubMed     Abstract available
     
     
     
206. PARK CK, Kim HS
     Clinicopathological Characteristics of Ovarian Metastasis from Colorectal and Pancreatobiliary Carcinomas Mimicking Primary Ovarian Mucinous Tumor.
     Anticancer Res. 2018;38:5465-5473.
     PubMed     Abstract available
     
     
     
207. HEINZE C, Omari J, Othmer M, Hass P, et al
     Image-guided Interstitial Brachytherapy in the Management of Metastasized Anal Squamous Cell Carcinoma.
     Anticancer Res. 2018;38:5401-5407.
     PubMed     Abstract available
     
     
     
208. TREDER M, Janssen S, Hollander NH, Schild SE, et al
     Role of Neoadjuvant Radio-chemotherapy for the Treatment of High Rectal Cancer.
     Anticancer Res. 2018;38:5371-5377.
     PubMed     Abstract available
     
     
     
209. RUBIO CA, Schmidt PT
     Are Non-dysplastic Crypts with Corrupted Shapes the Initial Recordable Histological Event in the Development of Sporadic Conventional Adenomas?
     Anticancer Res. 2018;38:5315-5320.
     PubMed     Abstract available
     
     
     August 2018
210. DAITOKU N, Miyamoto Y, Tokunaga R, Sakamoto Y, et al
     Controlling Nutritional Status (CONUT) Score Is a Prognostic Marker in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy.
     Anticancer Res. 2018;38:4883-4888.
     PubMed     Abstract available
     
     
     
211. ARAKAWA K, Hata K, Kawai K, Tanaka T, et al
     Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines.
     Anticancer Res. 2018;38:4871-4876.
     PubMed     Abstract available
     
     
     
212. HIRAYAMA K, Sudoh M, Shimizu H, Furuya S, et al
     Clinical Impact of Histological Heterogeneity in the Metastatic Lymph Nodes of Patients with Colorectal Cancer.
     Anticancer Res. 2018;38:4797-4803.
     PubMed     Abstract available
     
     
     
213. KARLBERG M, Stenstedt K, Hallstrom M, Ragnhammar P, et al
     Tumor Budding Versus Mismatch Repair Status in Colorectal Cancer - An Exploratory Analysis.
     Anticancer Res. 2018;38:4713-4721.
     PubMed     Abstract available
     
     
     
214. SIM JJ, Park MH, Baek JH, Lee H, et al
     Investigation into Enhancing Capecitabine Efficacy in Colorectal Cancer by Inhibiting Focal Adhesion Kinase Signaling.
     Anticancer Res. 2018;38:4667-4676.
     PubMed     Abstract available
     
     
     
215. LIU W, Zhang D, Tan SA, Liu X, et al
     Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous Prostate Cancer with Intact MMR: Diagnosis and Analysis of the Family Pedigree.
     Anticancer Res. 2018;38:4847-4852.
     PubMed     Abstract available
     
     
     
216. LEE YM, Yeo MK, Seong IO, Kim KH, et al
     Nuclear Expression of CD133 Is Associated with Good Prognosis in Patients with Colorectal Adenocarcinoma.
     Anticancer Res. 2018;38:4819-4826.
     PubMed     Abstract available
     
     
     
217. MIYAKITA H, Sadahiro S, Kamei Y, Ogimi T, et al
     Chemoradiotherapy-induced Changes in Mucinous Components in Rectal Cancer Tissue: Evaluation on High Iron Diamine-alcian Blue and Mucin 1 Staining.
     Anticancer Res. 2018;38:4783-4787.
     PubMed     Abstract available
     
     
     
218. TUTINO V, DE Nunzio V, Tafaro A, Bianco G, et al
     Cannabinoid Receptor-1 Up-regulation in Azoxymethane (AOM)-treated Mice After Dietary Treatment with Quercetin.
     Anticancer Res. 2018;38:4485-4491.
     PubMed     Abstract available
     
     
     
219. NAKAMURA M, Suetsugu A, Hasegawa K, Satake T, et al
     Color-coded Imaging Distinguishes Cancer Cells, Stromal Cells, and Recombinant Cancer-stromal Cells in the Tumor Microenvironment During Metastasis.
     Anticancer Res. 2018;38:4417-4423.
     PubMed     Abstract available
     
     
     July 2018
220. YOSHIDA Y, Sakamoto R, Kajitani R, Munechika T, et al
     Biweekly Administration of TAS-102 for Neutropenia Prevention in Patients with Colorectal Cancer.
     Anticancer Res. 2018;38:4367-4373.
     PubMed     Abstract available
     
     
     
221. LUO H, Nishi K, Ishikura S, Swain A, et al
     Growth Suppression of Human Colorectal Cancer Cells with Mutated KRAS by 3-Deaza-cytarabine in 3D Floating Culture.
     Anticancer Res. 2018;38:4247-4256.
     PubMed     Abstract available
     
     
     
222. YUN CW, Kim S, Lee JH, Lee SH, et al
     Melatonin Promotes Apoptosis of Colorectal Cancer Cells via Superoxide-mediated ER Stress by Inhibiting Cellular Prion Protein Expression.
     Anticancer Res. 2018;38:3951-3960.
     PubMed     Abstract available
     
     
     
223. CHABOWSKI M, Nowak A, Grzegrzolka J, Piotrowska A, et al
     Comparison of Microvessel Density Using Nestin and CD34 in Colorectal Cancer.
     Anticancer Res. 2018;38:3889-3895.
     PubMed     Abstract available
     
     
     
224. RUBIO CA, Schmidt PT
     Severe Defects in the Macrophage Barrier to Gut Microflora in Inflammatory Bowel Disease and Colon Cancer.
     Anticancer Res. 2018;38:3811-3815.
     PubMed     Abstract available
     
     
     
225. MAEDA K, Shibutani M, Otani H, Fukuoka T, et al
     Neoadjuvant Radiotherapy with Capecitabine Plus Bevacizumab for Locally Advanced Lower Rectal Cancer: Results of a Single-institute Phase II Study.
     Anticancer Res. 2018;38:4193-4197.
     PubMed     Abstract available
     
     
     
226. VYCITAL O, Dubova M, Palek R, Hosek P, et al
     The Impact of Immune Interaction on the Metastatic Infiltration of Colorectal Carcinoma to Lymph Nodes.
     Anticancer Res. 2018;38:4159-4167.
     PubMed     Abstract available
     
     
     
227. TUPY R, Mirka H, Mracek J, Priban V, et al
     Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging.
     Anticancer Res. 2018;38:4149-4152.
     PubMed     Abstract available
     
     
     
228. KIM S, Park SG, Song YJ, Park JK, et al
     Analysis of Anticancer Activity and Chemical Sensitization Effects of Dendropanax morbifera and Commersonia bartramia Extracts.
     Anticancer Res. 2018;38:3853-3861.
     PubMed     Abstract available
     
     
     June 2018
229. SAWAZAKI S, Numata M, Morita J, Maezawa Y, et al
     Safety of Laparoscopic Surgery for Colorectal Cancer in Patients with Severe Comorbidities.
     Anticancer Res. 2018;38:3767-3772.
     PubMed     Abstract available
     
     
     
230. VENALAINEN MK, Roine AN, Hakkinen MR, Vepsalainen JJ, et al
     Altered Polyamine Profiles in Colorectal Cancer.
     Anticancer Res. 2018;38:3601-3607.
     PubMed     Abstract available
     
     
     
231. ENKHBAT T, Nishi M, Takasu C, Yoshikawa K, et al
     Programmed Cell Death Ligand 1 Expression Is an Independent Prognostic Factor in Colorectal Cancer.
     Anticancer Res. 2018;38:3367-3373.
     PubMed     Abstract available
     
     
     
232. OKUNO T, Kawai K, Hata K, Murono K, et al
     SN-38 Acts as a Radiosensitizer for Colorectal Cancer by Inhibiting the Radiation-induced Up-regulation of HIF-1alpha.
     Anticancer Res. 2018;38:3323-3331.
     PubMed     Abstract available
     
     
     
233. ANGELOU A, Andreatos N, Antoniou E, Zacharioudaki A, et al
     A Novel Modification of the AOM/DSS Model for Inducing Intestinal Adenomas in Mice.
     Anticancer Res. 2018;38:3467-3470.
     PubMed     Abstract available
     
     
     
234. LING G, Lamprecht S, Shubinsky G, Osyntsov L, et al
     Mycophenolate Mofetil Alone and in Combination with Tacrolimus Inhibits the Proliferation of HT-29 Human Colonic Adenocarcinoma Cell Line and Might Interfere with Colonic Tumorigenesis.
     Anticancer Res. 2018;38:3333-3339.
     PubMed     Abstract available
     
     
     May 2018
235. RADES D, Dziggel L, Blanck O, Gebauer N, et al
     A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy.
     Anticancer Res. 2018;38:3111-3114.
     PubMed     Abstract available
     
     
     
236. TEI M, Otsuka M, Suzuki Y, Kishi K, et al
     Safety and Feasibility of Single-port Surgery for Colon Cancer in Octogenarians.
     Anticancer Res. 2018;38:2967-2972.
     PubMed     Abstract available
     
     
     
237. PATANKAR M, Vayrynen S, Tuomisto A, Makinen M, et al
     Micropapillary Structures in Colorectal Cancer: An Anoikis-resistant Subpopulation.
     Anticancer Res. 2018;38:2915-2921.
     PubMed     Abstract available
     
     
     
238. DESHWAR A, Margonis GA, Andreatos N, Barbon C, et al
     Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series.
     Anticancer Res. 2018;38:2891-2895.
     PubMed     Abstract available
     
     
     
239. CACEV T, Zapletal E, Musani V, Rako I, et al
     Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer.
     Anticancer Res. 2018;38:2841-2848.
     PubMed     Abstract available
     
     
     
240. TUTINO V, Defrancesco ML, Tolomeo M, DE Nunzio V, et al
     The Expression of Riboflavin Transporters in Human Colorectal Cancer.
     Anticancer Res. 2018;38:2659-2667.
     PubMed     Abstract available
     
     
     
241. CLOUSTON HW, Rees PA, Lamb R, Duff SE, et al
     Effect of Tissue Factor on Colorectal Cancer Stem Cells.
     Anticancer Res. 2018;38:2635-2642.
     PubMed     Abstract available
     
     
     
242. ALFONSO PG, Podesta MC, Martin AM, Codeisido MB, et al
     Chemotherapy Plus Bevacizumab as Neoadjuvant or Conversion Treatment in Patients with Colorectal Liver Metastases.
     Anticancer Res. 2018;38:3069-3077.
     PubMed     Abstract available
     
     
     
243. CUSHMAN TR, Venigalla S, Brooks ED, Lin C, et al
     Utilization of Neoadjuvant Intensity-modulated Radiation Therapy for Rectal Cancer in the United States.
     Anticancer Res. 2018;38:2923-2927.
     PubMed     Abstract available
     
     
     
244. JOO JW, Kim HS, Do SI, Sung JY, et al
     Expression of Zinc Finger and BTB Domain-containing 7A in Colorectal Carcinoma.
     Anticancer Res. 2018;38:2787-2792.
     PubMed     Abstract available
     
     
     April 2018
245. KAWAHARA H, Mouri T, Ishida K, Matsumoto N, et al
     Usefulness of TAS-102 as Third-line Chemotherapy for Metastatic Colorectal Cancer.
     Anticancer Res. 2018;38:2419-2422.
     PubMed     Abstract available
     
     
     
246. ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
     MicroRNA-96 Promotes Tumor Invasion in Colorectal Cancer via RECK.
     Anticancer Res. 2018;38:2031-2035.
     PubMed     Abstract available
     
     
     
247. LIN KM, Yang MD, Tsai CW, Chang WS, et al
     The Role of MTHFR Genotype in Colorectal Cancer Susceptibility in Taiwan.
     Anticancer Res. 2018;38:2001-2006.
     PubMed     Abstract available
     
     
     
248. LEE JH, Yoon YM, Han YS, Yun CW, et al
     Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein.
     Anticancer Res. 2018;38:1993-2000.
     PubMed     Abstract available
     
     
     
249. WANG W, Li Y, Chen Y, Chen H, et al
     Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer via the Wnt/Beta-Catenin Signaling Pathway in an Orthotopic Mouse Model.
     Anticancer Res. 2018;38:1917-1925.
     PubMed     Abstract available
     
     
     
250. RUBIO CA, Schmidt PT
     Morphological Classification of Corrupted Colonic Crypts in Ulcerative Colitis.
     Anticancer Res. 2018;38:2253-2259.
     PubMed     Abstract available
     
     
     
251. SIDERIS M, Donaldson AN, Hanrahan J, Grunwald M, et al
     Radiotherapy May Offer a Recurrence and Survival Benefit in Rectal Cancers Treated Surgically with Transanal Endoscopic Microsurgery: A Systematic Review and Meta-analysis.
     Anticancer Res. 2018;38:1879-1895.
     PubMed     Abstract available
     
     
     March 2018
252. ETO K, Kosuge M, Ohkuma M, Noaki R, et al
     Defunctioning Ileostomy Is a Key Risk Factor for Small Bowel Obstruction After Colorectal Cancer Resection.
     Anticancer Res. 2018;38:1789-1795.
     PubMed     Abstract available
     
     
     
253. FURUKE H, Komatsu S, Ikeda J, Tanaka S, et al
     Self-expandable Metallic Stents Contribute to Reducing Perioperative Complications in Colorectal Cancer Patients with Acute Obstruction.
     Anticancer Res. 2018;38:1749-1753.
     PubMed     Abstract available
     
     
     
254. SUENAGA M, Akiyoshi T, Shinozaki E, Fujimoto Y, et al
     A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer -ACTOR Study.
     Anticancer Res. 2018;38:1741-1747.
     PubMed     Abstract available
     
     
     
255. OKUGAWA Y, Shirai Y, Toiyama Y, Saigusa S, et al
     Clinical Burden of Modified Glasgow Prognostic Scale in Colorectal Cancer.
     Anticancer Res. 2018;38:1599-1610.
     PubMed     Abstract available
     
     
     
256. CHEN Y, Lee CH, Tseng BY, Tsai YH, et al
     AZD8055 Exerts Antitumor Effects on Colon Cancer Cells by Inhibiting mTOR and Cell-cycle Progression.
     Anticancer Res. 2018;38:1445-1454.
     PubMed     Abstract available
     
     
     
257. BABA T, Kokuryo T, Yamaguchi J, Yokoyama Y, et al
     Pre-exposure to Fluorouracil Increased Trifluridine Incorporation and Enhanced its Anti-tumor Effect for Colorectal Cancer.
     Anticancer Res. 2018;38:1427-1434.
     PubMed     Abstract available
     
     
     
258. NA K, Sung JY, Kim HS
     Clinicopathological Characteristics of High-grade Squamous Intraepithelial Lesions Involving Condyloma Acuminatum.
     Anticancer Res. 2018;38:1767-1774.
     PubMed     Abstract available
     
     
     
259. YOSHIKAWA K, Shimada M, Higashijima J, Nakao T, et al
     Ki-67 and Survivin as Predictive Factors for Rectal Cancer Treated with Preoperative Chemoradiotherapy.
     Anticancer Res. 2018;38:1735-1739.
     PubMed     Abstract available
     
     
     
260. KERR D, Laber D, Visweshwar N, Jaglal M, et al
     Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin.
     Anticancer Res. 2018;38:1711-1713.
     PubMed     Abstract available
     
     
     
261. LACZMANSKA I, Sasiadek M, Laczmanski L
     The Comparison Between Molecular Tumour Profiling in Microdissected and Surgical Tissue Samples.
     Anticancer Res. 2018;38:1415-1418.
     PubMed     Abstract available
     
     
     February 2018
262. SHINAGAWA T, Hata K, Morikawa T, Takiyama H, et al
     Protrusion on the Depressed Surface of Non-polypoid T1 Colorectal Cancer Is Associated with Venous Invasion.
     Anticancer Res. 2018;38:993-1002.
     PubMed     Abstract available
     
     
     
263. NUMATA M, Sawazaki S, Morita J, Maezawa Y, et al
     Comparison of Laparoscopic and Open Surgery for Colorectal Cancer in Patients with Severe Comorbidities.
     Anticancer Res. 2018;38:963-967.
     PubMed     Abstract available
     
     
     
264. KANG S, Oh SC, Min BW, Lee DH, et al
     Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
     Anticancer Res. 2018;38:787-794.
     PubMed     Abstract available
     
     
     
265. OSADA S, Gotoh A, Yokoi R, Tsuchiya H, et al
     Effective Timing of Surgical Resection of Colorectal Cancer Liver Metastases During Chemotherapy.
     Anticancer Res. 2018;38:737-743.
     PubMed     Abstract available
     
     
     
266. HAUSMANN D, Liu J, Budjan J, Reichert M, et al
     Image Quality Assessment of 2D versus 3D T2WI and Evaluation of Ultra-high b-Value (b=2,000 mm/s(2)) DWI for Response Assessment in Rectal Cancer.
     Anticancer Res. 2018;38:969-978.
     PubMed     Abstract available
     
     
     
267. RUBIO CA, DE Petris G, Puppa G
     Gut-associated Lymphoid Tissue (GALT) Carcinoma in Ulcerative Colitis.
     Anticancer Res. 2018;38:919-921.
     PubMed     Abstract available
     
     
     
268. BUNDSCHERER AC, Malsy M, Gruber MA, Graf BM, et al
     Acetaminophen and Metamizole Induce Apoptosis in HT 29 and SW 480 Colon Carcinoma Cell Lines In Vitro.
     Anticancer Res. 2018;38:745-751.
     PubMed     Abstract available
     
     
     
269. JUNG YY, Sung JY, Kim JY, Kim HS, et al
     Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.
     Anticancer Res. 2018;38:691-697.
     PubMed     Abstract available
     
     
     
270. LUNDBERG IV, Wikberg ML, Ljuslinder I, Li X, et al
     MicroRNA Expression in KRAS- and BRAF-mutated Colorectal Cancers.
     Anticancer Res. 2018;38:677-683.
     PubMed     Abstract available
     
     
     
271. CEAUSU AR, Ciolofan A, Cimpean AM, Magheti A, et al
     The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin.
     Anticancer Res. 2018;38:811-816.
     PubMed     Abstract available
     
     
     January 2018
272. KATSUKI T, Nakayama Y, Akiyama M, Sawatsubashi Y, et al
     Prognostic Significance of Mitochondrial Transcription Factor A Expression in Patients with Right- or Left-sided Colorectal Cancer.
     Anticancer Res. 2018;38:569-575.
     PubMed     Abstract available
     
     
     
273. TAKAHASHI H, Haraguchi N, Nishimura J, Hata T, et al
     The Severity of Anastomotic Leakage May Negatively Impact the Long-term Prognosis of Colorectal Cancer.
     Anticancer Res. 2018;38:533-539.
     PubMed     Abstract available
     
     
     
274. MIYAMOTO Y, Oki E, Emi Y, Tokunaga S, et al
     Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal Cancer.
     Anticancer Res. 2018;38:491-499.
     PubMed     Abstract available
     
     
     
275. SHAMOUN L, Kolodziej B, Andersson RE, Dimberg J, et al
     Protein Expression and Genetic Variation of IL32 and Association with Colorectal Cancer in Swedish Patients.
     Anticancer Res. 2018;38:321-328.
     PubMed     Abstract available
     
     
     
276. JO YK, Park NY, Shin JH, Jo DS, et al
     Up-regulation of UVRAG by HDAC1 Inhibition Attenuates 5FU-induced Cell Death in HCT116 Colorectal Cancer Cells.
     Anticancer Res. 2018;38:271-277.
     PubMed     Abstract available
     
     
     
277. YANG G, Qiu J, Wang D, Tao Y, et al
     Traditional Chinese Medicine Curcumin Sensitizes Human Colon Cancer to Radiation by Altering the Expression of DNA Repair-related Genes.
     Anticancer Res. 2018;38:131-136.
     PubMed     Abstract available
     
     
     
278. MURONO K, Kawai K, Hata K, Emoto S, et al
     Regimens of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.
     Anticancer Res. 2018;38:15-22.
     PubMed     Abstract available
     
     
     
279. SPELT L, Sasor A, Ansari D, Hilmersson KS, et al
     The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
     Anticancer Res. 2018;38:313-320.
     PubMed     Abstract available
     
     
     
280. GLEI M, Fischer S, Lamberty J, Ludwig D, et al
     Chemopreventive Potential of In Vitro Fermented Raw and Roasted Hazelnuts in LT97 Colon Adenoma Cells.
     Anticancer Res. 2018;38:83-93.
     PubMed     Abstract available
     
     
     December 2017
281. LIANG YH, Shao YY, Chen HM, Cheng AL, et al
     Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.
     Anticancer Res. 2017;37:7095-7104.
     PubMed     Abstract available
     
     
     
282. GKEKAS I, Novotny J, Pecen L, Strigard K, et al
     Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
     Anticancer Res. 2017;37:6563-6574.
     PubMed     Abstract available
     
     
     
283. YAMAMOTO S, Kanai T, Osumi K, Yo K, et al
     Anastomotic Leakage Using Linear Stapling Device with Pre-attached Bioabsorbable Polyglycolic Acid Felt After Laparoscopic Anterior Resection.
     Anticancer Res. 2017;37:7083-7086.
     PubMed     Abstract available
     
     
     
284. MIYATA T, Beppu T, Higashi T, Nakagawa S, et al
     A Glissonean Approach with Individual Isolation During Right Hemi-Hepatectomy After Portal Vein Embolization.
     Anticancer Res. 2017;37:7069-7071.
     PubMed     Abstract available
     
     
     
285. RUBIO CA
     Updated Histologic Classification of Adenomas and Carcinomas in the Colon of Carcinogen-treated Sprague-Dawley Rats.
     Anticancer Res. 2017;37:6667-6670.
     PubMed     Abstract available
     
     
     November 2017
286. KAJITANI T, Makiyama A, Arita S, Shimokawa H, et al
     Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer.
     Anticancer Res. 2017;37:6459-6468.
     PubMed     Abstract available
     
     
     
287. MERCIER J, Voutsadakis IA
     A Systematic Review and Meta-analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer.
     Anticancer Res. 2017;37:5925-5934.
     PubMed     Abstract available
     
     
     
288. CIRIMBEI C, Rotaru V, Chitoran E, Pavaleanu O, et al
     Immediate and Long-term Results of Radiofrequency Ablation for Colorectal Liver Metastases.
     Anticancer Res. 2017;37:6489-6494.
     PubMed     Abstract available
     
     
     October 2017
289. TAKIYAMA A, Tanaka T, Yamamoto Y, Hata K, et al
     Microsatellite Status of Primary Colorectal Cancer Predicts the Incidence of Postoperative Colorectal Neoplasms.
     Anticancer Res. 2017;37:5785-5790.
     PubMed     Abstract available
     
     
     
290. BAKALOVA R, Zhelev Z, Shibata S, Nikolova B, et al
     Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic" Versus "Onco-Suppressive" Reactive Oxygen Species.
     Anticancer Res. 2017;37:5449-5458.
     PubMed     Abstract available
     
     
     
291. TANASE T, Hamada C, Yoshino T, Ohtsu A, et al
     A Proposal for Progression-Free Survival Assessment in Patients with Early Progressive Cancer.
     Anticancer Res. 2017;37:5851-5855.
     PubMed     Abstract available
     
     
     
292. IDE S, Toiyama Y, Okugawa Y, Oki S, et al
     Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.
     Anticancer Res. 2017;37:5797-5804.
     PubMed     Abstract available
     
     
     
293. KAWAHARA H, Akiba T, Yanaga K
     Transanal Assisted Resection with Closure of Anal Canal for Lower Rectal Diseases.
     Anticancer Res. 2017;37:5767-5769.
     PubMed     Abstract available
     
     
     
294. TOKUNAGA T, Nishi M, Higashijima J, Yoshikawa K, et al
     Feasibility of Transanal Local Excision Following Chemoradiation for Lower Rectal Cancer.
     Anticancer Res. 2017;37:5617-5622.
     PubMed     Abstract available
     
     
     
295. SUNG JY, Na K, Kim HS
     Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma.
     Anticancer Res. 2017;37:5525-5531.
     PubMed     Abstract available
     
     
     
296. IKEMURA M, Hashida T
     Effect of Hyperglycemia on Antitumor Activity and Survival in Tumor-bearing Mice Receiving Oxaliplatin and Fluorouracil.
     Anticancer Res. 2017;37:5463-5468.
     PubMed     Abstract available
     
     
     September 2017
297. KANEKO M, Nozawa H, Emoto S, Murono K, et al
     Neoadjuvant Imatinib Therapy Followed by Intersphincteric Resection for Low Rectal Gastrointestinal Stromal Tumors.
     Anticancer Res. 2017;37:5155-5160.
     PubMed     Abstract available
     
     
     
298. ANNEDE P, Darreon J, Benkemouche A, Valdenaire S, et al
     Flattening Filter Free vs. Flattened Beams for Lung Stereotactic Body Radiation Therapy.
     Anticancer Res. 2017;37:5133-5139.
     PubMed     Abstract available
     
     
     
299. NONAKA T, Fukuda A, Maekawa K, Nagayoshi S, et al
     Clinical and Oncological Outcomes of Laparoscopic Lateral Pelvic Lymph Node Dissection in Advanced Lower Rectal Cancer: Single-institution Experience.
     Anticancer Res. 2017;37:5095-5100.
     PubMed     Abstract available
     
     
     
300. CARINI F, Mazzola M, Rappa F, Jurjus A, et al
     Colorectal Carcinogenesis: Role of Oxidative Stress and Antioxidants.
     Anticancer Res. 2017;37:4759-4766.
     PubMed     Abstract available
     
     
     
301. BAR JK, Lis-Nawara A, Grelewski P, Noga L, et al
     The Association Between HSP90/topoisomerase I Immunophenotype and the Clinical Features of Colorectal Cancers in Respect to KRAS Gene Status.
     Anticancer Res. 2017;37:4953-4960.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: